Industry News
Pharmaceutical Industry News
In a new episode of The Top Line,…
In a new episode of The Top Line, Salesforce’s president of regulated industries explains why life science companies should embrace digital transformation and rethink engagement with patients and providers.
The positive readout could move…
The positive readout could move Tukysa, which has been used for second-line, HER2-positive breast cancer, into the earlier, first-line maintenance setting.
With two Trump administration drug…
With two Trump administration drug pricing deals in the books and more likely on the way, the U.S. policy environment could soon stabilize for many Big Pharma companies. That put Johnson & Johnson in an
As BioNTech works to establish a…
As BioNTech works to establish a production footprint for mRNA vaccines in Africa, two EU groups have offered financial backing to the company's efforts.
Opioid Deaths Suddenly Dominate a Governor’s Race. Here’s What We Know.
Representative Mikie Sherrill, a New Jersey Democrat, said a firm once owned by her Republican opponent, Jack Ciattarelli, spread misinformation about opioids. His campaign has threatened to sue her for defamation.
W.H.O. Warns of Sharp Increase in Drug-Resistant Infections
The U.N. health agency found that one in six infections worldwide was resistant to the most commonly available antibiotics.
The FDA has tagged Novo Nordisk’s…
The FDA has tagged Novo Nordisk's newly acquired manufacturing facility in Indiana with an official action indicated label, which is the most severe of the three inspection classifications issued by the agency.
Syngene: Transforming Monoclonal…
Syngene: Transforming Monoclonal Antibody Manufacturing for the Next Wave of Biologics
With the launch of a new branded…
With the launch of a new branded initiative, Bristol Myers Squibb is crafting a recipe for both ramping up its Cobenfy rollout and boosting schizophrenia awareness and education.
The FDA has adjusted the label of…
The FDA has adjusted the label of Johnson & Johnson and Legend Biotech’s Carvykti, warning patients and doctors that use of the multiple myeloma treatment could increase the risk an intestinal inflammatory disorder which can
Germany’s LTS—whose…
Germany's LTS—whose bread-and-butter business revolves around developing and manufacturing drug delivery systems—is paying an undisclosed sum to purchase U.S. CDMO Renaissance Lakewood, which itself specializes in nasals sprays and sterile dosage forms.
Halozyme scoured very broadly for…
Halozyme scoured very broadly for potential acquisitions in the drug delivery field before landing on Elektrofi, Halozyme CEO Helen Torley said during an interview on the sidelines of Fierce Biotech Week in Boston.
Trump Cuts a Deal With AstraZeneca to Lower Drug Prices
The president and top health officials acknowledged using the leverage of tariff threats to forge an agreement. Other companies are still in negotiations with the White House.
President Donald Trump has been…
President Donald Trump has been pressuring top drugmakers to get on board with his drug pricing agenda for months. Now, AstraZeneca is ready to comply, MSNBC reports.
The 2025 edition of Time’s…
The 2025 edition of Time’s annual “best inventions” list saw the magazine expand the docket from 200 to 300 innovations—more than 10% of which comprise medical devices, pharmaceuticals and other novel products in the healthcare
Auto-injector specialist Ypsomed…
Auto-injector specialist Ypsomed is hopping on the United States manufacturing bandwagon, investing 200 million Swiss francs ($248 million) to build a plant in Holly Springs, North Carolina. It will be the first U.S. facility for
The Senate has passed a new…
The Senate has passed a new version of the Biosecure Act as part of an amendment to the National Defense Authorization Act for the upcoming fiscal year. While similar to last year's edition, this amendment
AstraZeneca and Daiichi Sankyo are…
AstraZeneca and Daiichi Sankyo are teeing up a TROP2 showdown with Gilead in first-line triple-negative breast cancer. China's InnoCare agreed to out-license three autoimmune candidates to Zenas. Lupin plans to invest $250 million to build
Pelthos Therapeutics is seeking…
Pelthos Therapeutics is seeking mothers who don’t mess around to raise awareness about the treatment of molluscum contagiosum.
Pharma representatives who…
Pharma representatives who received an invite to the summit have reportedly expressed “consternation” over the concern that the event’s host and guest list imply that the White House wants drugmakers to work with BlinkRx.